MIR5195

Across TCGA pan-cancer cohorts, MIR5195 Mutation is linked to patient survival in 2 of 34 cancer types, making it a survival-associated MIR5195 data layer compared with 20 for mass-spec protein.

The strongest signal is observed in lymphoid neoplasm diffuse large b-cell lymphoma (DLBC), where higher MIR5195 Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated MIR5195 expression acts as an unfavorable survival marker.

DLBC and SKCM are the cancer types where MIR5195 Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
DLBC	OS	Median	II,III,IV	0.172	0.949	<.001	30	view →
SKCM	OS	Median	All	0.361	0.786	.044	3	view →

Pink = unfavorable, green = favorable. Showing the 2 strongest of 2 lineages.

MIR5195–DLBC (OS)

Open the DLBC breakdown →